Waterdrop Inc. Achieves Significant Growth in Q4 2025

Waterdrop Inc. announced impressive financial results for Q4 and FY2025, with a significant rise in operating revenue. The company's Q4 net operating revenue surged by 105.5% year-over-year to 1,411.2 million RMB. This increase contributed to a net profit of 162.1 million RMB, marking a 62.7% rise from the previous year. For FY2025, Waterdrop's operating revenue grew by 43.5%, reaching 3,977.8 million RMB. The company declared a cash dividend as its financial health remains robust.

Waterdrop saw substantial gains in its insurance business, with a 125% YoY increase in insurance-related revenue for Q4. The integration of AI technology has been pivotal in enhancing operational efficiency and driving growth. Additionally, Waterdrop Medical Crowdfunding raised 72.3 billion RMB for 3.68 million patients, demonstrating the company's commitment to social impact.

Waterdrop's digital clinical trial solutions also expanded, enrolling 14,555 patients into 1,611 clinical programs by the end of 2025. The company's AI-driven approaches have underpinned its growth and its strategic focus on technology continues to reshape its operational landscape.